DOD Biotech PCL
SET:DOD

Watchlist Manager

DOD Biotech PCL

SET:DOD

Watchlist

Dividends

Discount Rate

Price: 2.46 THB -1.6% Market Closed

Market Cap: 1.1B THB

Have any thoughts about
DOD Biotech PCL?

Write Note

Write Note Create Alert Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

US	Fubotv Inc NYSE:FUBO	Media
US	Bank of America Corp NYSE:BAC	Banking
US	Palantir Technologies Inc NYSE:PLTR	Technology
US	Uber Technologies Inc NYSE:UBER	Road & Rail
CN	NIO Inc NYSE:NIO	Automobiles
US	Fluor Corp NYSE:FLR	Construction
US	Jacobs Engineering Group Inc NYSE:J	Professional Services
US	TopBuild Corp NYSE:BLD	Consumer products
US	Abbott Laboratories NYSE:ABT	Health Care
US	Chevron Corp NYSE:CVX	Energy
US	Occidental Petroleum Corp NYSE:OXY	Energy
US	Matrix Service Co NASDAQ:MTRX	Construction
US	Automatic Data Processing Inc NASDAQ:ADP	Technology
US	Qualcomm Inc NASDAQ:QCOM	Semiconductors
US	PayPal Holdings Inc NASDAQ:PYPL	Technology
US	Ambarella Inc NASDAQ:AMBA	Semiconductors

Add Price Alert

Price Target:

Last Price: 2.46 THB

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

Do you really want to delete this note?
This action cannot be undone.

Remove price alert for reaching

Delete

Cancel

DOD Alert

DOD Biotech PCL

2.46

-0.04 (-1.6%)

52 Week Range	1.65 3.9
Price Target

We'll email you a reminder when the closing price reaches THB.

Save Alert

Choose the stock you wish to monitor with a price alert.

	Fubotv Inc NYSE:FUBO	US
	Bank of America Corp NYSE:BAC	US
	Palantir Technologies Inc NYSE:PLTR	US
	Uber Technologies Inc NYSE:UBER	US
	NIO Inc NYSE:NIO	CN
	Fluor Corp NYSE:FLR	US
	Jacobs Engineering Group Inc NYSE:J	US
	TopBuild Corp NYSE:BLD	US
	Abbott Laboratories NYSE:ABT	US
	Chevron Corp NYSE:CVX	US
	Occidental Petroleum Corp NYSE:OXY	US
	Matrix Service Co NASDAQ:MTRX	US
	Automatic Data Processing Inc NASDAQ:ADP	US
	Qualcomm Inc NASDAQ:QCOM	US
	PayPal Holdings Inc NASDAQ:PYPL	US
	Ambarella Inc NASDAQ:AMBA	US

Delete Alert

This alert will be permanently deleted.

Remove note

Delete

Cancel

Ask me anything about

DOD Biotech PCL

What unique competitive advantages
does DOD Biotech PCL hold over its rivals?

What risks and challenges
does DOD Biotech PCL face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of DOD Biotech PCL.

What unique competitive advantages
does DOD Biotech PCL hold over its rivals?

What risks and challenges
does DOD Biotech PCL face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for DOD Biotech PCL.

Provide P/S
for DOD Biotech PCL.

Provide P/E
for DOD Biotech PCL.

Provide P/OCF
for DOD Biotech PCL.

Provide P/FCFE
for DOD Biotech PCL.

Provide P/B
for DOD Biotech PCL.

Provide EV/S
for DOD Biotech PCL.

Provide EV/GP
for DOD Biotech PCL.

Provide EV/EBITDA
for DOD Biotech PCL.

Provide EV/EBIT
for DOD Biotech PCL.

Provide EV/OCF
for DOD Biotech PCL.

Provide EV/FCFF
for DOD Biotech PCL.

Provide EV/IC
for DOD Biotech PCL.

Show me price targets
for DOD Biotech PCL made by professional analysts.

What are the Revenue projections
for DOD Biotech PCL?

How accurate were the past Revenue estimates
for DOD Biotech PCL?

What are the Net Income projections
for DOD Biotech PCL?

How accurate were the past Net Income estimates
for DOD Biotech PCL?

What are the EPS projections
for DOD Biotech PCL?

How accurate were the past EPS estimates
for DOD Biotech PCL?

What are the EBIT projections
for DOD Biotech PCL?

How accurate were the past EBIT estimates
for DOD Biotech PCL?

Compare the revenue forecasts
for DOD Biotech PCL with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of DOD Biotech PCL and its key competitors using the latest financial data.

Compare historical revenue growth rates
of DOD Biotech PCL against its competitors.

Analyze the profit margins
(gross, operating, and net) of DOD Biotech PCL compared to its peers.

Compare the P/E ratios
of DOD Biotech PCL against its peers.

Discuss the investment returns and shareholder value creation
comparing DOD Biotech PCL with its peers.

Analyze the financial leverage
of DOD Biotech PCL compared to its main competitors.

Show all profitability ratios
for DOD Biotech PCL.

Provide ROE
for DOD Biotech PCL.

Provide ROA
for DOD Biotech PCL.

Provide ROIC
for DOD Biotech PCL.

Provide ROCE
for DOD Biotech PCL.

Provide Gross Margin
for DOD Biotech PCL.

Provide Operating Margin
for DOD Biotech PCL.

Provide Net Margin
for DOD Biotech PCL.

Provide FCF Margin
for DOD Biotech PCL.

Show all solvency ratios
for DOD Biotech PCL.

Provide D/E Ratio
for DOD Biotech PCL.

Provide D/A Ratio
for DOD Biotech PCL.

Provide Interest Coverage Ratio
for DOD Biotech PCL.

Provide Altman Z-Score Ratio
for DOD Biotech PCL.

Provide Quick Ratio
for DOD Biotech PCL.

Provide Current Ratio
for DOD Biotech PCL.

Provide Cash Ratio
for DOD Biotech PCL.

What is the historical Revenue growth
over the last 5 years for DOD Biotech PCL?

What is the historical Net Income growth
over the last 5 years for DOD Biotech PCL?

What is the current Free Cash Flow
of DOD Biotech PCL?

Discuss the annual earnings per share (EPS)
trend over the past five years for DOD Biotech PCL.

EV/EBITDA
Enterprise Value to EBITDA

-20.3

Current

10.1

Median

10.4

Industry

Lower than median

Lower than industry value

Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.

EV/EBITDA

-20.3

Enterprise Value

1.2B THB

EBITDA

-57.8m THB

All Countries

Forward Multiples

			Market Cap	EV/EBITDA
TH	D	DOD Biotech PCL SET:DOD	1.1B THB	-20.3
FR		L'Oreal SA PAR:OR	184.1B EUR	18.9
UK		Unilever PLC LSE:ULVR	118.3B GBP	177.6
IN		Hindustan Unilever Ltd NSE:HINDUNILVR	5.9T INR	39.6
UK		HALEON PLC LSE:HLN	34B GBP	15.2
DE		Beiersdorf AG XETRA:BEI	27.9B EUR	16.1
US		Estee Lauder Companies Inc NYSE:EL	24.7B USD	12
JP		Kao Corp TSE:4452	3.1T JPY	15.2
IN		Godrej Consumer Products Ltd NSE:GODREJCP	1.3T INR	42.2
MY	N	Nova Wellness Group Bhd KLSE:NOVAMSC	66.7B MYR	-14 147.6
IN		Dabur India Ltd NSE:DABUR	956.9B INR	38.9

				EBITDA Growth
TH	D	DOD Biotech PCL SET:DOD	Average EV/EBITDA: 41.8 Negative Multiple: -20.3	N/A
FR		L'Oreal SA PAR:OR	18.9	32%
UK		Unilever PLC LSE:ULVR	177.6	21%
IN		Hindustan Unilever Ltd NSE:HINDUNILVR	39.6	31%
UK		HALEON PLC LSE:HLN	15.2	16%
DE		Beiersdorf AG XETRA:BEI	16.1	11%
US		Estee Lauder Companies Inc NYSE:EL	12	51%
JP		Kao Corp TSE:4452	15.2	54%
IN		Godrej Consumer Products Ltd NSE:GODREJCP	42.2	48%
MY	N	Nova Wellness Group Bhd KLSE:NOVAMSC	Negative Multiple: -14 147.6	1 313%
IN		Dabur India Ltd NSE:DABUR	38.9	45%

EV/EBITDA Forward Multiples

Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward

EV/EBITDA

N/A

2-Years Forward

EV/EBITDA

N/A

3-Years Forward

EV/EBITDA

N/A

DOD Biotech PCL
SET:DOD

EV/EBITDA
Enterprise Value to EBITDA

EV/EBITDA Forward Multiples

See Also

Company

Help

Tools

Stocks

DOD Biotech PCL SET:DOD

EV/EBITDA Enterprise Value to EBITDA

EV/EBITDA Forward Multiples

See Also

Company

Help

Tools

Stocks

DOD Biotech PCL
SET:DOD

EV/EBITDA
Enterprise Value to EBITDA